HCPCS Level IIdrugActive
J9321
Inj epcoritamab-bysp 0.16 mg
BETOS: O1D
Effective: 2024-01-01
Description
Injection, epcoritamab-bysp, 0.16 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Epkinly
Manufacturer
Genmab US, Inc.
HCPCS Dosage
0.16 MG
Billing Units
25.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.